Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page
- Check6 days agoChange DetectedNew history entries were added for 2026-02-17 and 2026-02-18, including an updated Study Status (version 171). The 2025-11-26 entry was removed.SummaryDifference0.2%

- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed in the page history. This is a minor site revision update and does not affect the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page history now includes a new revision entry for v3.4.1 and removes the older v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe history view now includes a glossary toggle and color-coded highlights for additions (green) and deletions (red). The revision label was updated to v3.4.0, and older items such as No FEAR Act data and v3.3.4 appear removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe history shows a new revision label v3.3.4 added and the previous v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.